Results for tag: "Natalizumab"

Natalizumab is a monoclonal antibody used to treat immune disorders such as multiple sclerosis (MS) and Crohn's disease. It works by blocking the migration of certain white blood cells, which are responsible for causing inflammation in the body. Natalizumab is administered intravenously and is usually given as a single dose every four weeks. It is generally well tolerated, with the most common side effects being headache, nausea, and fatigue. Natalizumab is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2004. It has become an important treatment option for people with MS and Crohn's disease, as it has been shown to reduce the frequency and severity of relapses. It is also used to treat other immune disorders, such as ulcerative colitis and psoriasis. Natalizumab is marketed by several companies, including Biogen, Merck, and Genentech. It is also available in generic form from several generic drug manufacturers. Show Less Read more